OpenVSafe by OpenVAERS
Search V-safe

L6U-60847-26239

3 vaccinations 1 coded response 23 check-ins 1 free-text entry 1 call case
Sex
Male
Age at first dose
0-4
ZIP prefix
037 / NH
Registered
2022-06-26
Relationship
Child or adolescent in my care
Guardian
DCX-33902-92374
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-26
    Registered in v-safe
  2. 2022-08-30
    Dose 1 — Pfizer-BioNTech
  3. 2022-08-30
    Health check-in — day 0, dose 1, under 3
    Feeling: Good · Site: Pain · None
    Under 3 check-in
  4. 2022-08-31
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Sleepiness, Loss of appetite
    Under 3 check-in
  5. 2022-09-01
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Fair · Irritability/crying
    Under 3 check-in
  6. 2022-09-02
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-09-03
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Sleepiness
    Under 3 check-in
  8. 2022-09-04
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Sleepiness, Diarrhea
    Under 3 check-in
  9. 2022-09-05
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · Diarrhea
    Under 3 check-in
  10. 2022-09-06
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  11. 2022-09-20
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  12. 2022-09-28
    Dose 2 — Pfizer-BioNTech
  13. 2022-09-28
    Health check-in — day 0, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  14. 2022-09-29
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Fair · Irritability/crying
    Under 3 check-in
  15. 2022-09-30
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Loss of appetite
    Under 3 check-in
  16. 2022-10-01
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  17. 2022-10-02
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · Loss of appetite
    Under 3 check-in
  18. 2022-10-04
    Health check-in — days 1–6 daily, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  19. 2022-10-05
    Health check-in — day 7, dose 2, under 3
    Feeling: Good · None
    Under 3 check-in
  20. 2022-10-12
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  21. 2022-10-19
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  22. 2022-10-26
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  23. 2022-11-02
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  24. 2022-11-09
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  25. 2022-11-28
    Dose 3 — Pfizer-BioNTech
  26. 2022-12-28
    Survey response — 3 months, dose 2, under 3
    MedDRA: Conjunctivitis bacterial, Ear infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Ear infection and bacterial conjunctivitis.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-12-28
    Report sent to call center — 3 months, dose 2, under 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  28. 2022-12-29
  29. 2023-05-29
    Health check-in — 6 months, dose 3, under 3
    Feeling: Good
    Under 3 check-in

Vaccinations

DoseDateManufacturerCo-administered
12022-08-30Pfizer-BioNTech No
22022-09-28Pfizer-BioNTech No
32022-11-28Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-12-28

Symptoms: Ear infection and bacterial conjunctivitis.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDConjunctivitis bacterial · · ✓
SDEar infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release